Allogenic platelet gel in the treatment of pressure sores: a pilot study

Silvia Scevola1, Giovanni Nicoletti, Federica Brenta

  • 1Department of Plastic and Reconstructive Surgery, University of Pavia -Salvatore Maugeri Foundation Research and Care Institute, Pavia, Italy. silvia.scevola@fsm.it

Insights

Platelet gel shows promise for chronic wound healing, particularly pressure sores in spinal cord injury patients. Early application accelerates granulation tissue formation, but prolonged use offers no additional benefit over standard care.

Area of Science:

  • Plastic Surgery
  • Wound Healing
  • Regenerative Medicine

Background:

  • Platelet gel is a popular treatment for chronic ulcers, but its efficacy is debated.
  • Pressure sores are common in spinal cord injury patients, posing significant treatment challenges.

Purpose of the Study:

  • To evaluate the effectiveness of allogenic platelet gel versus standard care for chronic pressure sores.
  • To compare healing times and clinical improvement in ulcers treated with platelet gel.

Main Methods:

  • A prospective randomized trial involving 13 spinal cord injury patients with 16 pressure sores.
  • Ulcers were randomized to receive either allogenic platelet gel or current best practice wound care.
  • Clinical improvement and granulation tissue onset were monitored over 20 months.

Main Results:

  • 15 out of 16 ulcers showed clinical improvement regardless of treatment group.
  • No significant difference in volume reduction was observed between platelet gel and standard care.
  • Platelet gel significantly accelerated the onset of granulation tissue proliferation.

Conclusions:

  • Platelet gel is effective in initiating the healing process for chronic ulcers, especially within the first two weeks.
  • Prolonged platelet gel treatment did not demonstrate advantages over established wound care protocols.
  • Allogenic platelet gel represents a valuable option for early-stage wound healing acceleration.